Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Oncorus Inc

ONCR
Current price
Last closed 0.13 USD
ISIN US68236R1032
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 287 944 USD
Yield for 12 month -100.00 %
1Y
3Y
5Y
10Y
15Y
ONCR
21.11.2021 - 28.11.2021

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts. Address: 50 Hampshire Street, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ONCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -69 700 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -32.24 %
PEG Ratio
Return On Equity TTM -124.56 %
Wall Street Target Price 5 USD
Revenue TTM
Book Value 1.19 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.48 USD
Diluted Eps TTM -3.48 USD
Most Recent Quarter I 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ONCR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

-5 %

Dividend History ONCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 26.12.2023
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date 29.12.2023

Stock Valuation ONCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.378
Price Book MRQ 0.1057

Financials ONCR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ONCR

For 52 weeks

0.12 USD 0.12 USD
50 Day MA 0.026 USD
Shares Short Prior Month 158 893
200 Day MA 0.1 USD
Short Ratio 0.74
Shares Short 447 723
Short Percent 2.01 %